Neurosoft Bioelectronics

Switzerland
Hasle, Lucerne, Switzerland, 1202

Company profile

Neurosoft Bioelectronics company profile

Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system. Neural implants are medical devices made of electrodes that can record or stimulate the brain, spinal cord, or peripheral nerves to monitor or treat patients suffering from neurological disorders. However, current clinical devices are too stiff compared to the soft tissues of the body, which limits benefits for patients. At Neurosoft Bioelectronics, we have developed a new generation of soft and conformable implantable electrodes that seamlessly interface with the nervous tissues and can improve clinical outcomes for patients.

Business identity

Contact email
[email protected]
Phone number
+41788761469
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-02-01

Headquarters

Postal code
1202
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
9
Total equity funding
$168,834
Last funding
Seed / 2025-09-16
Last equity funding
Seed
Investors
8
Lead investors
7
Founders
1
Articles
14

Founders and investors

Founders

Nicolas Vachicouras

Lead investors

European Innovation CouncilFONGIT Innovation FundInnosuisseKickfundMassChallengeVentureVenture Kick

Investors

European Innovation CouncilKickfundMassChallengePlug and PlayVenture Kick